We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live ... CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. Show more
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.38 | -4.61538461538 | 29.9 | 30.15 | 26.73 | 338214 | 28.17570821 | CS |
| 4 | -1.09 | -3.68118878757 | 29.61 | 31.16 | 26.73 | 503129 | 29.74005335 | CS |
| 12 | -3.74 | -11.5933044017 | 32.26 | 36.73 | 26.73 | 717035 | 30.26760577 | CS |
| 26 | -4.83 | -14.4827586207 | 33.35 | 40.47 | 26.73 | 673162 | 33.79193472 | CS |
| 52 | -16.69 | -36.9166113692 | 45.21 | 50.23 | 25.77 | 647559 | 34.63924999 | CS |
| 156 | -0.48 | -1.65517241379 | 29 | 50.23 | 25.77 | 669851 | 34.90820248 | CS |
| 260 | -0.48 | -1.65517241379 | 29 | 50.23 | 25.77 | 669851 | 34.90820248 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
